Encycle Therapeutics

A proprietary chemistry platform from the laboratory of Dr. Andrei Yudin at the University of Toronto allows efficient synthesis of uniquely substituted ring systems comprising six to twenty or more contiguous atoms. Our core Discovery capability focuses on the design of molecules that address emerging principles in the chemical space required to mediate protein-protein interactions. The company's collaborative programs reflect the evolving understanding in this space and in the identification of key drug targets.
Company Growth (employees)
Type
Private
HQ
Toronto, CA
Founded
2012
Size (employees)
9 (est)-10%
Encycle Therapeutics was founded in 2012 and is headquartered in Toronto, CA

Encycle Therapeutics Office Locations

Encycle Therapeutics has an office in Toronto
Toronto, CA (HQ)
314 101 College St

Encycle Therapeutics Data and Metrics

Summary Metrics

Founding Date

2012

Total Funding

$4.6 m

Latest funding size

$2.1 m

Time since last funding

almost 2 years

Investors

Encycle Therapeutics's latest funding round in September 2015 was reported to be $2.1 m. In total, Encycle Therapeutics has raised $4.6 m

Traffic Overview of Encycle Therapeutics

Encycle Therapeutics Company Life and Culture

You may also be interested in